CORT Corcept Therapeutics
- 24.520
- -0.540-2.15%
- 25.000
- +0.480+1.96%
Corcept Therapeutics News
Corcept Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Swisher Daniel N JR
Corcept Therapeutics | 10-Q: Quarterly report
Corcept Therapeutics | 8-K: CORCEPT THERAPEUTICS ANNOUNCES FIRST QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE
Corcept Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Corcept Therapeutics | DEFA14A: Others
Corcept Therapeutics | ARS: Annual Report to Security Holders
Corcept Therapeutics | 8-K: Current report
Corcept Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director MAHONEY DAVID L
Corcept Therapeutics | DEF 14A: Definitive information statements
Corcept Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Lyon Joseph Douglas
Corcept Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Corcept Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Lyon Joseph Douglas
Corcept Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Swisher Daniel N JR
Corcept Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Corcept Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Maduck Sean
Corcept Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-INGALLS & SNYDER, LLC(8.0%)
Corcept Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Corcept Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Maduck Sean
Corcept Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Lyon Joseph Douglas
Corcept Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Maduck Sean
Analysis
Price Target
No Data
